CYDY: Hoffman Robert E. reports a stock award

By AlphaYouPublished Oct 21, 2026Form 4

Stocks in this disclosure

Reported activity

Hoffman Robert E.

Reporting filer

Hoffman Robert E. reports a stock award, not an open-market purchase or sale, in CytoDyn Inc.. Form 4 filed Oct 21, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Non-qualified stock option (right to buy) (derivative)	Hoffman Robert E.	2026-10-20	A	Grant or award	2500000	0	2,500,000	1 day	Filed terms security Title: Non-qualified stock option (right to buy) conversion Or Exercise Price: 0.25 transaction Date: 2026-10-20 transaction Form Type: 4 transaction Code: A equity Swap Involved: false transaction Shares: 2500000 id: F1 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F2 expiration Date: 2036-10-16 underlying Security Title: Common Stock underlying Security Shares: 2500000 shares Owned Following Transaction: 2500000 direct Or Indirect Ownership: D

Owner: Hoffman Robert E.
Date: 2026-10-20
Code: A
Action: Grant or award
Quantity: 2500000
Price: 0
Following holdings: 2,500,000
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Non-qualified stock option (right to buy)
conversion Or Exercise Price: 0.25
transaction Date: 2026-10-20
transaction Form Type: 4
transaction Code: A
equity Swap Involved: false
transaction Shares: 2500000
id: F1
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F2
expiration Date: 2036-10-16
underlying Security Title: Common Stock
underlying Security Shares: 2500000
shares Owned Following Transaction: 2500000
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Hoffman Robert E.: Chief Executive Officer.
F1: This grant was approved by the Company's Compensation Committee on October 16, 2026, pursuant to the Issuer's 2012 Equity Incentive Plan (the "Plan").
F2: 625,000 shares will vest on October 16, 2027, and the balance will vest in equal monthly installments beginning on November 16, 2027 and ending on October 16, 2030, subject to Continuous Service (as the term is defined in the Plan).

Prepared automatically from public filing data. Report a correction.